Squarepoint Ops LLC Tcr2 Therapeutics Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.11 - $2.94 $61,253 - $85,348	29,030 New	29,030 $84,000
Q1 2022 May 16, 2022	SELL	$2.4 - $4.71 $100,620 - $197,466	-41,925 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.58 - $8.34 $117,605 - $214,154	25,678 Added 158.05%	41,925 $195,000
Q3 2021 Nov 15, 2021	SELL	$8.44 - $18.35 $1.02 Million - $2.21 Million	-120,655 Reduced 88.13%	16,247 $138,000
Q2 2021 Aug 16, 2021	BUY	$16.41 - $24.71 $836,516 - $1.26 Million	50,976 Added 59.33%	136,902 $2.25 Million
Q1 2021 May 17, 2021	BUY	$20.38 - $34.07 $1.34 Million - $2.24 Million	65,772 Added 326.35%	85,926 $1.9 Million
Q4 2020 Feb 16, 2021	BUY	$19.0 - $32.63 $382,926 - $657,625	20,154 New	20,154 $623,000
Q1 2020 May 15, 2020	SELL	$6.01 - $16.01 $83,761 - $223,131	-13,937 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$12.17 - $17.88 $169,613 - $249,193	13,937 New	13,937 $199,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.